Exelixis (EXEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. New drug ...
After hours: January 17 at 7:58:10 PM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback